Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion
Atrial Fibrillation, Defibrillators, Persistent Atrial Fibrillation
About this trial
This is an interventional treatment trial for Atrial Fibrillation focused on measuring Atrial fibrillation, Refractory atrial fibrillation, Double sequential external defibrillation
Eligibility Criteria
Inclusion Criteria:
- Atrial Fibrillation patients admitted to the CCU for DC cardioversion, and refractory to at least two trials of DC cardioversion
Exclusion Criteria:
- Patients with Atrial Fibrillation not requiring DC cardioversion
- Patients with Atrial Fibrillation who reverted after a maximum of two trials of DC cardioversion
Sites / Locations
- American University of Beirut Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Third trial of DC cardioversion
Double sequential external defibrillation
Patients with atrial fibrillation who fail to revert to sinus rhythm after two failed DC cardioversion attempts will receive a third trial of DC cardioversion (Standard of care)
Patients with atrial fibrillation who fail to revert to sinus rhythm after two failed DC cardioversion attempts will receive DSED